These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10567331)

  • 1. Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury.
    Morgan EN; Boyle EM; Yun W; Kovacich JC; Canty TG; Chi E; Pohlman TH; Verrier ED
    Circulation; 1999 Nov; 100(19 Suppl):II365-8. PubMed ID: 10567331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activating factor acetylhydrolase decreases lung reperfusion injury.
    Kim JD; Baker CJ; Roberts RF; Darbinian SH; Marcus KA; Quardt SM; Starnes VA; Barr ML
    Ann Thorac Surg; 2000 Aug; 70(2):423-8. PubMed ID: 10969656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction.
    Serebruany VL; Gurbel PA; Murugesan SR; Lowry DR; Sturm E; Svetlov SI
    Cardiology; 1998 Oct; 90(2):127-30. PubMed ID: 9778550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
    Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study.
    Winkler K; Winkelmann BR; Scharnagl H; Hoffmann MM; Grawitz AB; Nauck M; Böhm BO; März W
    Circulation; 2005 Mar; 111(8):980-7. PubMed ID: 15710755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits.
    Arakawa H; Qian JY; Baatar D; Karasawa K; Asada Y; Sasaguri Y; Miller ER; Witztum JL; Ueno H
    Circulation; 2005 Jun; 111(24):3302-9. PubMed ID: 15956136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification and localization of platelet-activating factor acetylhydrolase from bovine seminal plasma.
    Hough SR; Parks JE
    J Androl; 1997; 18(5):540-8. PubMed ID: 9349753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor interaction with tumor necrosis factor in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Calapai G; Bussolino F; Caputi AP
    J Lipid Mediat; 1993 Aug; 8(1):53-65. PubMed ID: 8257777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-activating factor (PAF) up-regulates plasma and tissue PAF-acetylhydrolase activity in the rat: effect of cycloheximide.
    Wang H; Tan XD; Qu XW; Chang H; Remick DG; Gonzalez-Crussi F; Hsueh W
    Pediatr Res; 1997 Nov; 42(5):597-603. PubMed ID: 9357930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses.
    Henig NR; Aitken ML; Liu MC; Yu AS; Henderson WR
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):523-7. PubMed ID: 10934081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury.
    Boyle EM; Kovacich JC; Hèbert CA; Canty TG; Chi E; Morgan EN; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 1998 Jul; 116(1):114-21. PubMed ID: 9671905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase.
    Furukawa M; Lee EL; Johnston JM
    Pediatr Res; 1993 Aug; 34(2):237-41. PubMed ID: 8233731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor acetylhydrolase inhibits alveolar macrophage activation in vivo.
    Bulger EM; Gourlay D; Cuschieri J; Jelacic S; Staudenmeyer K; Garcia I; Maier RV
    Shock; 2003 Jul; 20(1):17-22. PubMed ID: 12813363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective role of transgenic PAF-acetylhydrolase II in mouse models of focal cerebral ischemia.
    Umemura K; Kato I; Hirashima Y; Ishii Y; Inoue T; Aoki J; Kono N; Oya T; Hayashi N; Hamada H; Endo S; Oda M; Arai H; Kinouchi H; Hiraga K
    Stroke; 2007 Mar; 38(3):1063-8. PubMed ID: 17272759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor antagonism: a new concept in the management of regional myocardial ischemia-reperfusion injury.
    Loucks EB; Symersky P; Qayumi AK
    J Invest Surg; 1997; 10(6):321-38. PubMed ID: 9654389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
    Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
    Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction.
    Liu PY; Li YH; Wu HL; Chao TH; Tsai LM; Lin LJ; Shi GY; Chen JH
    J Thromb Haemost; 2006 May; 4(5):1023-8. PubMed ID: 16689754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of platelet-activating factor antagonism in the management of myocardial infarction.
    Loucks EB; Qayumi AK; Godin DV; English JC; Lim SP; Al Mahmeed T; Gul S
    Can J Cardiol; 2000 Apr; 16(4):497-504. PubMed ID: 10787465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotection by platelet-activating factor acetylhydrolase in a mouse model of transient cerebral ischemia.
    Wu Y; Wang L; Dai C; Ma G; Zhang Y; Zhang X; Wu Z
    Neurosci Lett; 2014 Jan; 558():26-30. PubMed ID: 24189491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.